Abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” to be presented at conference main stage
Toronto, ON September 16, 2015 – MEMOTEXT is pleased to announce that our Founder and President Amos Adler will be a main stage speaker at Stanford Medicine X 2015. Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.
Read More
How MEMOTEXT helps you achieve it
Posted on October 13, 2015 by Noah Nemoy
If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?
Read More
“The MEMOTEXT Toolkit” walks readers through the problem of patient non-adherence, explaining the methodology behind our digital health interventions
Posted on July 23, 2015 by Noah Nemoy
MEMOTEXT is pleased to unveil “The MEMOTEXT Toolkit” Whitepaper. Authored by MEMOTEXT’s President and Founder Amos Adler M.Sc., Director of Scientific Development Bill Simpson P.hD(c) and Miki Peer P.hD(c), the document explains both the problem of patient adherence and outlines the science behind MEMOTEXT’s methodology.
Read More
MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015
Posted on July 23, 2015 by Noah Nemoy
MEMOTEXT is pleased to announce that our President and Founder Amos Adler will be speaking at Stanford Medicine X 2015! Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.
Read More
MEMOTEXT is named by HIT Consultant as one of the Top 20 Canadian Digital Health Technology Start-Ups to Watch
Posted on July 23, 2015 by Noah Nemoy
Earlier this month HIT Consultant, released their list of the Top 20 Canadian digital health companies to lookout for. The companies on the list were selected for their potential for growth and represented disparate areas of digital health, including digital health solutions, diagnostics, and patient centred care. MEMOTEXT managed to not only make the Top 20, but was also one of the Top 10 digital health start-ups in Eastern Canada, and the only company of the 20 with an exclusive focus on patient adherence.
Read More
Posted on July 6, 2015 by Noah Nemoy
Last week, MEMOTEXT Founder and President Amos Adler was invited to both attend and present at the 14th Annual Patient Adherence & Access Summit, or PAAS2015 in Philadelphia. While there MEMOTEXT had the opportunity to share in the discussion of the latest issues regarding patient adherence and access, to medication.
Read More
Director of Scientific Development Bill Simpson unveils our new BAM adherence metric
Posted on June 26, 2015 by Bill Simpson
2 weeks ago MEMOTEXT had the privilege of presenting our new Balanced Adherence Metric (BAM) at the inaugural Science of Medication Adherence Conference (SMA2015), hosted by the University of Pittsburgh Centre for Pharmaceutical Policy and Prescribing.
Read More
Posted on June 17, 2015 by Noah Nemoy
On Monday morning, MEMOTEXT’s Founder and President Amos Adler and PerformRx’s Director of Drug Therapy Management Programs & Outcomes Lauren C. Megargell, had the honor to jointly present the results of our HealthNHandSM asthma adherence program to the The Digital Transformation of Patient Care: New Avenues for Pharma Growth Seminar. The seminar was organized by the Consulate General of Canada in New York’s Canadian Technology Accelerator (CTA) Health IT Philadelphia as part of BIO2015.
Read More
Posted on June 09, 2015 by Amos Adler
We’ve just got back from the awesomeness that was Health Datapalooza 2015! Where to start? #HDP was 3 days of some of the most enthusiastic and exciting health data conversations we’ve had in years. With D.C.’s Marriott Wardman Park packed with digital health nerds, it was almost non-stop presentations, demonstrations and general health data game-on.
Read More
MEMOTEXT to present at both Washington D.C.’s Health Datapalooza 2015 and Pittsburgh’s SMA 2015 this week
Washington, D.C. June 1, 2015 – MEMOTEXT Corp. announces today the upcoming presentation of the Balanced Adherence Metric (BAM). The BAM will be presented tomorrow by MEMOTEXT’s Director of Scientific Development Bill Simpson, Ph.D. Candidate in Neuroscience, at the inaugural Science of Medication Adherence conference (SMA 2015) at the University of Pittsburgh. MEMOTEXT also has a delegation at Washington D.C.’s Health Datapalooza 2015 including Founder and President of MEMOTEXT Amos Adler, M.Sc. Health Datapalooza 2015 runs from today until Wednesday and MEMOTEXT will be present for the entire duration.
Read More